Has anyone been offerred this? -
"QUVIVIQ (daridorexant) – Europe’s first dual orexin receptor antagonist – is now available for patients with chronic insomnia disorder in Italy and Germany"
https://www.nice.org.uk/guidance/ta922/chapter/3-Committee-discussion
https://www.idorsia.com/investors/news-and-events/media-releases/media-release-details?id=2875642
My daughter had a sleep study in June 21, after an initial phone appt in June 2020.
This followed appts with Dr Gall, POTS neurocardiologist at Kings.
We weren't really expecting much, but the feedback was good.
The study had shown poor sleep efficiency at 65%. Is usually in the 90s for young adults. Amount of deep sleep was small and very fragmented. There were only a couple of sessions of REM, which occurred towards the end of her sleep (usually much earlier). The initial time to get to sleep was over an hour. There was a great deal of N1, which is light sleep and should only be about 5% of total.
The doc was very understanding re the life-changing impact ME is having on sleep and daily function, accepted that the NHS ME/CFS clinics had not helped, that sleep hygiene measures made no difference.
The hospital is going thro the stages of approving the above drug and he is quite hopeful that she would be a good candidate to try it.
She will do some insomnia CBT first... online. But she is OK with that.
This might be of significant help. Even a small inprovement, could make a big difference.